Quick Test Multi-Drugs Drug of Abuse Screen Rapid Test Panel

Name: Quick Test Multi-Drugs Drug of Abuse Screen Rapid Test Panel
Brand: HangZhou Testsea biotechnology Co., Ltd.
SKU: 1998219285

Zhejiang, ChinaHangZhou Testsea biotechnology Co., Ltd.

US$0.10-0.12

1,000 Pieces

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Type

IVD rapid test kit

Cut-off

30/50/100/300/500/1000/1500ng/Ml

Model NO.

108550

MOQ

1000PCS

Shelf Life

24 Months

Specimen

Urine

Format

Cassette / Panel /Cup

Certificate

CE, ISO 13485

OEM

Available

Storage

4-30°c

Package

25PCS/Box

Brand

Testsealabs

Transport Package

Carton

Specification

25pcs/box 40pcs/box

Trademark

Testsealabs

Origin

China

Production Capacity

1000000PC Per Day

Company profile

HangZhou Testsea biotechnology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2022-04-08Nearest Port: Shanghai, Ningbo, ShenzhenAverage Response Time: ≤8.97h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryTestsea Biotechnology, based in Hangzhou, China, is a company founded in 2015 specializing in the R&D, production, and sale of in vitro diagnostic and veterinary products. The company holds ISO 9001 and GMP certifications, indicating robust quality management systems. With over 10 production lines and an annual production output between US$50 million and US$100 million, Testsea demonstrates substantial production capability. The company exports extensively, with 90% of sales derived from international markets. Testsea emphasizes innovation through its development of core technologies for diagnostic testing and offers a wide range of rapid test products.

Supplier typeTestsea Biotechnology is a trading company and manufacturer/factory based in Zhejiang, China.

CertificationsThe company holds ISO 9001 and GMP certifications, indicating adherence to quality management standards.

R&D capabilityThe company focuses on R&D and has built detection platforms, indicating strong innovation capabilities.

Production capacityWith over 10 production lines and an annual output of US$50M - US$100M, the company has substantial production capacity.

Client casesThe company's products are used globally in over 100 countries for various rapid diagnostic applications.